India Ciprofloxacin Market to grow at an impressive rate During the Forecast Period
Growing prevalence of
bacterial infections is expected to drive the growth of India ciprofloxacin
market.
According to
TechSci Research report, “India Ciprofloxacin Market By Composition (Single
v/s Combinational), By Source (In-house v/s Contract Manufacturing
Organizations), By Form (Powder, Suspension, Capsule, Tablet, Eye Drops, Ear
Drop, Injection, Others), By Route of Administration (Oral, Ophthalmic, Otic,
Intravenous, Others), By Distribution Channel (Online v/s Offline), By
Application (Urinary Tract Infections, Lower Respiratory Infections, Nosocomial
Pneumonia, Skin structure Infections, Bone and Joint infections,
Intra-abdominal Infections, Acute Sinusitis, Conjunctivitis, Acute Otitis Externa,
Others), By End User (Adult v/s Pediatric), By Company, By Region, Forecast
& Opportunities, FY2026”, the India ciprofloxacin market
is expected to grow at an impressive rate during the forecast period on account
of the increasing application in the treatment of bone and joint infections,
intra-abdominal infections, skin infections, typhoid fever, among others.
Additionally, ciprofloxacin is present in WHOs list of essential medicine and
is recognized as a critically important medicine for human beings. This in turn
is expected to positively influence the market growth through FY2026. However,
side effects such as nausea, vomiting, rashes, diarrhea, stomach pain, among
others associated with intake of ciprofloxacin can restrict the market growth
during the forecast period. Also, severe side effects such as nerve damage,
hallucinations, among others can further impede the market growth over the next
five years. Moreover, stringent regulatory impositions on ciprofloxacin are
further expected to hamper the market growth until FY2026. Also, the black box
warning label on ciprofloxacin is further expected to slow down the market
growth over the next few years.
Browse XX market data
Tables and XX Figures spread through XXX Pages and an in-depth TOC on" India Ciprofloxacin Market"
https://www.techsciresearch.com/report/india-ciprofloxacin-market/5152.html
The India
Ciprofloxacin market is segmented based on composition, source, form, route of
administration, distribution channel, application, end user, company and
region. Based on source, the market can be split in in-house and contract
manufacturing organizations. The contract manufacturing organizations segment
is expected to witness significant growth during the forecast period on account
of the increasing outsourcing being done by the major pharmaceutical companies
for the manufacturing of APIs and drugs so that they can focus on their R&D
activities and expansion plans. Additionally, these organizations have the
capability to produce and provide bulk quantities of formulation to their
clients at affordable prices and in lesser time. Based on form, the market can
be categorized into powder, suspension, capsule, tablet, eye drops, ear drop,
injection and others. The tablet segment is expected to dominate the market
since it can accommodate a large amount of API as compared to the other
counterparts. While capsule segment is expected to register the highest growth
during the forecast period on account of the associated benefits such as fast
action, tamper resistance, higher rate of absorption, among others. Based on
route of administration, the market can be fragmented into oral, ophthalmic,
otic, intravenous and others. The oral route is expected to dominate the market
owing to the benefits such as absorption along the complete length of GI tract,
self-administration, easy availability, pain free route of drug administration,
among others. Based on distribution channel, the market can be split into
online and offline. The offline channel is expected to dominate the market
owing to the consumer preference for buying medicines from a pharmacy or drug
store. The online segment is also expected to register significant growth over
the next few years. This can be ascribed to the emergence of several online
pharmacies and doorstep drug delivery e-commerce platforms in the country.
Cipla
Ltd., Aurobindo Pharma Ltd., Sun Pharmaceuticals Industries Ltd., Dr. Reddy’s
Laboratories Ltd., Wockhardt Limited, Glenmark Pharmaceuticals Ltd., Cadila
Healthcare Ltd., Neuland Laboratories Ltd., Aarti Drugs Ltd., Indoco Remedies
Ltd and others are some of the leading players operating in India ciprofloxacin
market. Companies operating in the market are using organic strategies such as
product launches, mergers and acquisitions, research collaborations to boost
their share.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=5152
Customers can
also request for 10% free customization on this report.
“India ciprofloxacin market is
expected to witness growth during the forecast period on account of the growing
demand for the drug in treatment of skin infections, respiratory tract
infections, gastrointestinal infections, urogenital infections, among others.
Besides, supportive government policies and schemes that have been launched to
increase the production of API in the country is further expected to create
lucrative opportunities for the market growth over the next few years.” said Mr. Karan
Chechi, Research Director with TechSci Research, a research based India
management consulting firm.
“India Ciprofloxacin Market By Composition
(Single v/s Combinational), By Source (In-house v/s Contract Manufacturing
Organizations), By Form (Powder, Suspension, Capsule, Tablet, Eye Drops, Ear
Drop, Injection, Others), By Route of Administration (Oral, Ophthalmic, Otic,
Intravenous, Others), By Distribution Channel (Online v/s Offline), By
Application (Urinary Tract Infections, Lower Respiratory Infections, Nosocomial
Pneumonia, Skin structure Infections, Bone and Joint infections,
Intra-abdominal Infections, Acute Sinusitis, Conjunctivitis, Acute Otitis Externa,
Others), By End User (Adult v/s Pediatric), By Company, By Region, Forecast
& Opportunities, FY2026”, has evaluated
the future growth potential of India ciprofloxacin market and provides
statistics & information on market size, structure and future market
growth. The report intends to provide cutting-edge market intelligence and help
decision makers take sound investment decisions. Besides, the report also
identifies and analyzes the emerging trends along with essential drivers,
challenges and opportunities in India ciprofloxacin market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]